ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
13.23
-0.06 (-0.45%)
Nov 6, 2026, 4:00 PM EST - Market closed
ADARx Pharmaceuticals Revenue
ADARx Pharmaceuticals had revenue of $746.00K in the quarter ending June 30, 2026, with 258.65% growth. This brings the company's total for the last twelve months to $6.13M. In the year 2025, ADARx Pharmaceuticals had annual revenue of $3.45M. That makes ADARx Pharmaceuticals the 39,348th largest company in the world by revenue and 5,202nd in the United States.
Revenue (ttm)
$6.13M
Revenue Growth
n/a
P/S Ratio
241.96
Revenue / Employee
$61,270
Employees
100
Market Cap
1.48B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.45M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ADRX News
- 20 days ago - ADARx Pharmaceuticals initiated with an Outperform at LifeSci Capital - TheFly
- 20 days ago - ADARx Pharmaceuticals initiated with an Overweight at JPMorgan - TheFly
- 20 days ago - ADARx Pharmaceuticals initiated with a Buy at TD Cowen - TheFly
- 20 days ago - ADARx Pharmaceuticals initiated with an Overweight at Morgan Stanley - TheFly
- 20 days ago - ADARx Pharmaceuticals initiated with a Buy at UBS - TheFly
- 5 weeks ago - ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering - GlobeNewsWire
- 5 weeks ago - Opening Day: Amaero, Bamboo Insurance postpone IPOs - TheFly
- 6 weeks ago - ADARx Pharmaceuticals opens at $22.10, IPO priced at $17 per share - TheFly